İpek Çelikağ

机构：University of Bern, TuBerculosis Vaccine Initiative, Institute of Social and Preventive Medicine · ORCID：0000-0002-2172-6463

发表论文 5 篇 · 总被引 15 次 · h-index 1

代表论文

• Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study (2025 · Clinical Infectious Diseases · 被引 14)
• Novel integrase mutations linked to genotypic DTG resistance in non-B HIV-1 strains from African participants: The DTG RESIST study (2025 · medRxiv · 被引 1)
• Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study (2026 · Journal of Antimicrobial Chemotherapy)
• Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study. (2026 · Open Access CRIS of the University of Bern)
• Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study (2026 · Zurich Open Repository and Archive (University of Zurich))